InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（10 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
10
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Brazzell Romulus K, Directeur Médical. Director active across 2 companies, notably Kala Pharmaceuticals, Inc.. Aggregated, 15 disclosures have been logged. Breakdown: 0 buy · 10 sells. Total volume traded: €141k. Activity tracked since 28 June 2021. The latest transaction was disclosed on 22 October 2025 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Brazzell Romulus K
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报15 总计
46,748 股@ US$0.8333.6% 占其流量Common StockSEC:0001298079-25-000003:0
5,251 股@ US$4.0127.5% 占其流量Common StockSEC:0001415889-25-018318:0
3,687 股@ US$3.7425.4% 占其流量Common StockSEC:0001415889-25-015678:0
10,100 股0Common StockSEC:0001415889-25-001061:0
5,489 股@ US$4.7568.5% 占其流量Common StockSEC:0001415889-24-018373:0
2,002 股@ US$6.0931.5% 占其流量Common StockSEC:0001415889-24-015223:0
6,500 股0Common StockSEC:0001415889-24-000770:0
49,356 股0Common StockSEC:0001415889-23-010284:0
17,916 股Common StockSEC:0001415889-23-009135:0
12,800 股0Common StockSEC:0001415889-23-000638:0
261 股@ US$6.512.1% 占其流量Common StockSEC:0001415889-22-010879:0
3,144 股@ US$0.370.0071% mcap1.4% 占其流量Common StockSEC:0001415889-22-007061:0
3,504 股@ US$1.309.8% 占其流量Common StockSEC:0001415889-22-000404:0
12,757 股@ US$1.8048.0% 占其流量Common StockSEC:0001415889-21-005010:0
3,034 股@ US$5.7735.5% 占其流量Common StockSEC:0001415889-21-003258:0
15 条申报中的 15 条
About Brazzell Romulus K
Brazzell Romulus K is Directeur Médical at Kala Pharmaceuticals, Inc. and KALA BIO, Inc. Across 15 filings in total, the 15 sampled filings run from 2021-06-29 to 2025-10-24 and show EUR 0 of buys and EUR 140622 of sells, with the transaction nature listed as Cession.
